Deep sequence-coupled biopanning

Working in close collaboration with Dr. Bryce Chackerian and Dr. David Peabody at the University of New Mexico, the Frietze Lab has developed a novel technology for investigating the specificity of antibodies in serum from humans.  This technology has been used to investigate antibody responses to Dengue virus, Chlamydia trachomatis, and ovarian cancer.